Policy

Patient-centered medical home practices provided better preventive care and disease management with less resource utilization than practices not pursuing PCMH status.

Competitive bidding characterizes market-based proposals to control Medicare spending, but in this first empirical study of bidding in Medicare, we find that competition is lacking.

Modest increases in adherence to medication regimens among Medicare patients with heart failure were associated with lower Medicare spending in 3 major drug classes.

We examined the impact of clinical complexity defined by comorbidity count and illness burden on comprehensive diabetes care, including blood pressure, glycemic, and lipid management.

Managed care organizations have the opportunity to identify potential opioid misuse and implement care coordination interventions, which can enhance safety and streamline patient pain management.

Michael E. Chernew, PhD; Lee N. Newcomer, MD, MHA; and Sandra M. Swain, MD; examine the treatment benefits, cost concerns, and insurance coverage strategies for pertuzumab.

Earlier this week, Kaiser Health News released an analysis of Medicare data which showed that approximately 2200 hospitals will face penalties this October for having too many patients readmitted for care within 30 days of discharge.

This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.

This article reports a unique statewide initiative in Minnesota to improve orders for high-tech diagnostic imaging tests while reducing their overall frequency and costs.

This framework suggests new meaningful use measures and guidance for prioritizing implementation of different health information technology functionalities, based on their expected financial effects.

Patients who often change medical groups have the highest healthcare costs. The improved coordination of an accountable care organization may reduce those costs.

This content is brought to you by Amgen This video summarizes the complex process of creating biologics from start to finish and describes some of the unique challenges-- and tremendous effort-- involved in delivering safe and effective biologics.